| Metric | შპს ჯი-ი-ეს-ეი ფარმაცევტიკალს | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾5.7m₾5.5m | ₾2.36bn₾2.11bn |
| Revenue growth | 2.4% | 11.8% |
| Profitability | ||
| EBITDA | ₾2.7m₾1.6m | — |
| EBITDA margin | 48.1%29.8% | — |
| Net profit | ₾2.6m₾1.6m | ₾1.24bn₾1.12bn |
| Net margin | 46.4%29.8% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾13.5m₾10.6m | ₾37.66bn₾31.77bn |
| Total equity | ₾11.7m₾9.1m | ₾5.45bn₾4.75bn |
| ROE | 22.4%18.1% | 22.8%23.6% |